Recently, it was reported that nontoxic doses of β-thujaplicin inhibit the migration of A549 lung cancer cells through suppression of matrix metalloproteinases and induction of apoptosis via caspases-9 and -3 activation [12]. This evidence concerns the gene CASP9 and lung carcinoma.